You have 9 free searches left this month | to do more
Showing 1 - 25 of
>10,000 items
Trials Per Page
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
T
Multiple Myeloma Turkish Prospective Patient Registry
Recruiting
  • Multiple Myeloma
  • Relapse Multiple Myeloma
    • Istanbul, Turkey
      Medipol University
    2021-10-04
    Oct 4, 2021
    U
    Denosumab for Smoldering Multiple Myeloma
    Recruiting
    • Smoldering Multiple Myeloma
    • Rochester, New York
      University of Rochester
    2021-07-07
    Jul 7, 2021
    D
    A Phase II Trial If Nivolumab, Lenalidomide and Dexamethasone in High Risk Smoldering Myeloma
    Suspended
    • Smoldering Multiple Myeloma
    • Boston, Massachusetts
      Dana Farber Cancer Institute
    2022-01-04
    Jan 4, 2022
    D
    Trial of Combination of Ixazomib and Lenalidomide and Dexamethasone in Smoldering Multiple Myeloma
    Active, not recruiting
    • Smoldering Multiple Myeloma
    • Boston, Massachusetts
      Dana Farber Cancer Institute
    2022-03-15
    Mar 15, 2022
    W
    Treatment of Selinexor in Combination With Clarithromycin, Pomalidomide and Dexamethasone for Relapsed Refractory Multiple Myeloma Patients
    Recruiting
    • Myeloma Multiple
    • +2 more
    • Brooklyn, New York
    • +1 more
    2022-01-20
    Jan 20, 2022
    A
    Survival Outcomes of Multiple Myeloma Patients Admitted on Assiut Clinical Hematology Unit
    Not yet recruiting
    • Multiple Myeloma Survival Outcome
    • Bone marrow biopsy and compete blood count
    • (no location specified)
    2021-11-14
    Nov 14, 2021
    C
    Descartes-25 in Relapsed/Refractory Multiple Myeloma
    Recruiting
    • Multiple Myeloma
    • Relapse Multiple Myeloma
    • Bethesda, Maryland
    • +1 more
    2021-12-02
    Dec 2, 2021
    B
    Expanded Access to Elotuzumab (Empliciti) for Multiple Myeloma
    No longer available
    • Multiple Myeloma
    • Elotuzumab
    • (no location specified)
    2021-11-17
    Nov 17, 2021
    H
    A Study of HG146 Capsule in Chinese Subjects With Relapsed and Refractory Multiple Myeloma
    Recruiting
    • Multiple Myeloma
    • Relapsed and Refractory Multiple Myeloma
    • Chengdu, Sichuan, China
      HitGen Inc
    2022-03-16
    Mar 16, 2022
    R
    Compassionate Use (CU) of REGN5458 for Patients With Relapsed or Refractory Multiple Myeloma (MM)
    Available
    • Multiple Myeloma
    • (no location specified)
    2021-12-09
    Dec 9, 2021
    B
    Study of Dara-Pembro for Multiple Myeloma Patients
    Withdrawn
    • Multiple Myeloma
    • (no location specified)
    2022-01-26
    Jan 26, 2022
    N
    Carfilzomib, Lenalidomide, and Dexamethasone for Smoldering Multiple Myeloma
    Active, not recruiting
    • Multiple Myeloma
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    2022-04-07
    Apr 7, 2022
    Z
    Plasma-free Replacement in Patients With Multiple Myeloma - 2021
    Completed
    • Multiple Myeloma
    • Plasma-free procedure
    • Wuhan, Hubei, China
      Zhongnan Hospital of Wuhan University
    2022-02-10
    Feb 10, 2022
    C
    Descartes-11 in Multiple Myeloma - 2021
    Completed
    • Multiple Myeloma
    • Descartes-11
    • +2 more
    • Bethesda, Maryland
    • +1 more
    2022-03-10
    Mar 10, 2022
    W
    A Phase II Study of Daratumumab, Clarithromycin, Pomalidomide And Dexamethasone (D-ClaPd) In Multiple Myeloma Patients Previously Exposed to Daratumumab
    Recruiting
    • Multiple Myeloma
    • +2 more
    • New York, New York
      Weill Cornell Medicine - Multiple Myeloma Center
    2021-11-18
    Nov 18, 2021
    M
    TriPRIL CAR T Cells in Multiple Myeloma
    Recruiting
    • Multiple Myeloma
    • +2 more
    • TriPRIL CAR T Cells
    • +2 more
    • Boston, Massachusetts
      Massachusetts General Hospital Cancer Center
    2021-10-28
    Oct 28, 2021
    M
    LCI-HEM-MYE-CRD-002: Carfilzomib-Revlimid-Dexamethasone-Elotuzumab in Relapsed/Refractory Multiple Myeloma
    Active, not recruiting
    • Multiple Myeloma
    • Charlotte, North Carolina
      Levine Cancer Institute
    2022-01-21
    Jan 21, 2022
    U
    Iberdomide Maintenance Therapy in Patients With Multiple Myeloma
    Not yet recruiting
    • Multiple Myeloma
    • (no location specified)
    2021-12-15
    Dec 15, 2021
    S
    ASCT With Nivolumab in Patients With Multiple Myeloma
    Recruiting
    • Multiple Myeloma
    • Saint Petersburg, Russian Federation
      Boris V Afanasyev, MD, Prof.
    2022-04-04
    Apr 4, 2022
    I
    Phase II Clinical Trial of ITF2357 In Patients With Relapsed/Refractory Multiple Myeloma - 2010
    Terminated
    • Multiple Myeloma
    • Cagliari, Italy
      Presidio Ospedaliero R. Binaghi
    2022-01-18
    Jan 18, 2022
    S
    B Cell Maturation Antigen Targeted CAR-T Cells in Treatment With Relapsed and Refractory Multiple Myeloma
    Recruiting
    • Multiple Myeloma
    • +2 more
    • BCMA CAR-T cells
    • Shenzhen, Guangdong, China
      Li Yu
    2021-12-07
    Dec 7, 2021
    Y
    Multiparametric Imaging in Multiple Myeloma - 2021
    Completed
    • Multiple Myeloma
    • C11 Methionine positron emission tomography
    • Boston, Massachusetts
      Massachusetts General Hospital
    2021-09-15
    Sep 15, 2021
    A
    Pembrolizumab for the Treatment of Relapsed or Refractory Multiple Myeloma After Anti-BCMA CAR-T Therapies
    Not yet recruiting
    • Multiple Myeloma
    • +4 more
    • Pembrolizumab
    • San Francisco, California
      University of California, San Francisco
    2022-03-23
    Mar 23, 2022
    W
    Isatuximab, Bendamustine, and Prednisone in Refractory Multiple Myeloma
    Recruiting
    • Multiple Myeloma
    • Isatuximab
    • +2 more
    • Saint Louis, Missouri
      Washington University School of Medicine
    2022-04-01
    Apr 1, 2022
    U
    The Myeloma Pack: A Multi-Modality Educational Intervention Strategy to Engage Patients With Multiple Myeloma
    Active, not recruiting
    • Multiple Myeloma
    • ARM A EARLY INTERVENTION GROUP
    • ARM B DELAYED INTERVENTION GROUP
    • Birmingham, Alabama
      University of Alabama at Birmingham
    2022-01-25
    Jan 25, 2022